Speciality Medicines IPO Subscription Reaches 1.01x with Mixed Category Response

Speciality Medicines' initial public offering has recorded an overall subscription of 1.01x, reflecting a measured response from the investment community across various investor categories.

Subscription Performance by Category

The IPO subscription data shows distinct patterns across different investor segments:

Category Subscription Level Qualified Institutional Buyers (QIB) 1x Non-Institutional Buyers (bHNI) 2.68x Non-Institutional Buyers (sHNI) 0.1x Retail 0.19x Employees 0x Total Subscribed 1.01x

Category-wise Analysis

The Qualified Institutional Buyers category achieved full subscription at exactly 1x, indicating measured institutional interest. Among Non-Institutional Buyers, the big HNI segment demonstrated notable enthusiasm with 2.68x subscription, significantly oversubscribing their allocated portion.

Conversely, the small HNI category recorded minimal participation at 0.1x subscription, while the retail investor segment showed limited interest with 0.19x subscription. The employee category registered no subscription activity during the period.

Overall Market Response

The overall subscription level of 1.01x positions the Speciality Medicines IPO as marginally oversubscribed, with the strong performance in the big HNI category helping to offset the undersubscription in retail and small HNI segments. The balanced institutional participation at 1x subscription provides stability to the overall subscription numbers.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.